ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities

Radhika Nair1, Wee Siang Teo1, Vivek Mittal2

  • 1Cancer Research Division & Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia.

Insights

Inhibitor of differentiation (ID) proteins are crucial for cancer stem cell maintenance and tumor progression. Targeting these proteins offers new clinical opportunities for treating various malignancies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Stem Cell Biology

Background:

  • Inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors.
  • ID proteins regulate stem cell self-renewal, lineage commitment, and niche interactions.
  • Deregulated ID protein expression is linked to cancer development.

Purpose of the Study:

  • To review the latest findings on the role of ID proteins in neoplastic progression.
  • To discuss the clinical opportunities presented by targeting ID proteins in cancer.
  • To highlight the parallels between ID protein functions in physiological stem cells and cancer.

Main Methods:

  • Literature review of recent research on ID proteins in cancer.
  • Analysis of ID protein functions in cancer stem cell maintenance, proliferation, and metastasis.
  • Exploration of ID protein roles in tumor microenvironment remodeling and endothelial progenitor cell activity.

Main Results:

  • ID proteins are essential for cancer stem cell self-renewal and proliferation across various malignancies.
  • ID proteins contribute to metastatic dissemination by influencing the tumor microenvironment.
  • ID proteins promote the proliferation and mobilization of tumor-associated endothelial progenitor cells.

Conclusions:

  • ID proteins play a central role in neoplastic progression, mirroring their functions in normal stem cells.
  • Targeting ID proteins presents promising clinical strategies for cancer therapy.
  • Further research into ID protein functions can unlock new therapeutic avenues.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K